DNB ASA:企業の戦略・SWOT・財務情報

◆英語タイトル:DNB ASA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1140
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DNB ASA – Strategy, SWOT and Corporate Finance Report
Summary

DNB ASA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DNB ASA (DNB) offers personal banking, business banking, and corporate and institutional banking. Personal banking includes accounts, cards, loans, mortgages, securities, insurance, pension, and foreign exchange. Business banking contains financing, investment products, asset management, transaction banking, market reports, and foreign exchange. Corporate and institutional banking consists of investment banking, global market services, and corporate banking. It serves individuals, SMEs, corporate, and institutions through a network of branch offices, ATMs, and online portals. The company has presence in the Americas, Europe, and Asia. DNB is headquartered in Oslo, Norway.

Scope

- Detailed information on DNB ASA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DNB ASA in the form of a SWOT analysis
- An in-depth view of the business model of DNB ASA including a breakdown and examination of key business segments
- Intelligence on DNB ASA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DNB ASA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DNB ASA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DNB ASA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DNB ASA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
DNB ASA: Company Overview 7
DNB ASA: Overview and Key Facts 7
DNB ASA: Overview 7
DNB ASA: Key Facts 7
DNB ASA: Key Employees 9
DNB ASA: Key Employee Biographies 11
DNB ASA: Locations and Subsidiaries 13
DNB ASA: Key Competitors 15
DNB ASA: Corporate Financial Deals Activity 16
DNB ASA: Financial Deals Overview 16
DNB ASA: Top Deals 2014 – 2018YTD* 17
DNB ASA: Divestments 18
DNB ASA: Recent Developments 19
DNB ASA: News and Events Summary 19
DNB ASA: Business Expansion 21
DNB ASA: Business Reorganization 22
DNB ASA: Corporate Governance 22
DNB ASA: Financial Deals 23
DNB ASA: Financial Performance 24
DNB ASA: Regulatory and Legal Events 24
DNB ASA: Strategy and Operations 25
Appendix 26
Contact Us 26
Methodology 26
About MarketLine 27

List of Tables
Table 1: DNB ASA: Key Facts
Table 2: DNB ASA: Key Employees
Table 3: DNB ASA: Locations and Subsidiaries
Table 4: DNB ASA: Key Competitors
Table 5: DNB ASA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: DNB ASA: Top Deals 2014 - 2018YTD*
Table 7: DNB ASA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 8: DNB ASA: Divestments by Geography (2014 - YTD*2018)
Table 9: DNB ASA: News and Events Summary
Table 10: DNB ASA: Business Expansion
Table 11: DNB ASA: Business Reorganization
Table 12: DNB ASA: Corporate Governance
Table 13: DNB ASA: Financial Deals
Table 14: DNB ASA: Financial Performance
Table 15: DNB ASA: Regulatory and Legal Events
Table 16: DNB ASA: Strategy and Operations

List of Figures
Figure 1: DNB ASA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: DNB ASA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 3: DNB ASA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[DNB ASA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IES Holdings Inc (IESC):企業の財務・戦略的SWOT分析
    IES Holdings Inc (IESC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Dermira Inc (DERM):企業の財務・戦略的SWOT分析
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Air Liquide Welding France, S.A.:企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Henry Schein Inc (HSIC)-医療機器分野:企業M&A・提携分析
    Summary Henry Schein, Inc. (Henry Schein) is a distributor of healthcare products and services. Its product and service portfolio consists of dental products, medical products, animal health products, software and technology and other value-added services. It offers generic and branded pharmaceutica …
  • University of Ulster-製薬・医療分野:企業M&A・提携分析
    Summary University of Ulster (UU) is an educational service provider that offers undergraduate and postgraduate educational programs. The university’s business activities include teaching and learning, research and innovation, widening access to education, and technology and knowledge transfer. Its …
  • Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its p …
  • Genedrive Plc (GDR):企業の財務・戦略的SWOT分析
    Genedrive Plc (GDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Carmell Therapeutics Corp:製品パイプライン分析
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio encompasses adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for tot …
  • OTE Group:企業の戦略・SWOT・財務分析
    OTE Group - Strategy, SWOT and Corporate Finance Report Summary OTE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Phosphagenics Ltd:企業の戦略・SWOT・財務情報
    Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report Summary Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Welch Allyn Inc:企業の戦略的SWOT分析
    Welch Allyn Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Pier 1 Imports, Inc.:企業の戦略・SWOT・財務情報
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oval Medical Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oval Medical Technologies Ltd (Oval Medical), a subsidiary of SMC Ltd, is a developer of patient-centric autoinjectors. The company offers cyclic olefin polymeric (COP) drug containers, which are injection moulded for customization. Based on its subcutaneous platform, the company is developi …
  • InMed Pharmaceuticals Inc (IN):企業の財務・戦略的SWOT分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • Tahoe Resources Inc.:企業の戦略・SWOT・財務情報
    Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Banco do Estado do Rio Grande do Sul SA:企業の戦略・SWOT・財務分析
    Banco do Estado do Rio Grande do Sul SA - Strategy, SWOT and Corporate Finance Report Summary Banco do Estado do Rio Grande do Sul SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆